However, we found that miR-145, miR-29b and miR-410 only have less regulated by CCL3, and we revealed another miRNA (miR-374b) that could target VEGF-A, and inhibit angiogenesis in human osteosarcoma cells. This evidence concerns the gene CCL3 and osteosarcoma.